Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,192,826
-$2,012,076 QoQ
Shares Held
13,992
-49.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#405
of 1,603 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Jun 30, 2026CallValue
$203,736
CallShares
1,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $1,287,408,532 across 15 Drug Manufacturers - General names. NVS ranks #12 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,085,383 | $581,119,768 | |
| 2 | AMGN |
Amgen Inc
|
1,128,681 | $408,717,963 | |
| 3 | LLY |
ELI LILLY & Co
|
81,240 | $97,441,701 | |
| 4 | AZN |
Astrazeneca PLC
|
329,087 | $62,401,476 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
409,174 | $51,695,043 | |
| 6 | ABBV |
AbbVie Inc.
|
198,249 | $49,887,378 | |
| 7 | JNJ |
Johnson & Johnson
|
34,909 | $8,865,838 | |
| 8 | PFE |
Pfizer Inc
|
330,300 | $7,953,624 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,192,826 | 13,992 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $203,736 | 1,300 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $305,500 | 2,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $4,204,902 | 27,528 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $551,480 | 4,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $4,126,173 | 29,928 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $413,610 | 3,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $4,068,798 | 31,728 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,477,723 | 334,499 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,930,662 | 80,110 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,282,862 | 54,289 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,263,577 | 28,374 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,651,621 | 156,412 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,613,092 | 161,409 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,072,686 | 129,471 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $12,635,924 | 137,347 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $59,144,178 | 651,942 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $91,059,599 | 1,197,995 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $135,884,679 | 1,607,532 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $169,528,963 | 1,931,954 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $157,299,487 | 1,798,325 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $144,054,815 | 1,761,492 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $143,369,152 | 1,571,341 | Shares | Sole | 2021-08-16 | |
| 2020-06-30 | $5,925,931 | 67,849 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $25,588,110 | 310,347 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||